Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

The ProtecT trial is a randomized controlled trial that compared active monitoring, radical prostatectomy, and radiotherapy for men with localized prostate cancer. It involved 1,643 participants and aimed to provide contemporary data on the outcomes of these treatment options. The study found no significant difference in prostate cancer-specific mortality between